Skip to main content

Table 1 ACS Group: Clinical profile and aPL prevalence

From: Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates

  ACS+: HIV+ ACS+: HIV- p value
Demographic Profile:    
Black African n(%) 30(100) 30(100) 1.0
Mean Age (years) 43 ± 7 54 ± 13 < 0.001
Men (%) 20(67) 18(60) N/S
Coronary risk factors n(%):    
Smoking 22(73) 10(33) 0.004
Diabetes Mellitus 1(3) 7(23) 0.05
Hypertension 7(23) 23(77) < 0.001
Total cholesterol (mmol/l) 3.6 ± 1.0 4.6 ± 1.4 0.003
LDL cholesterol (mmol/l) 2.2 ± 0.9 3.0 ± 1.2 0.003
HDL cholesterol (mmol/l) 0.8 ± 0.3 1.1 ± 0.4 < 0.001
Triglycerides (mmol/l) 1.4 ± 0.8 1.1+/-0.4 N/S
BMI (kg/m2) 25 ± 5 28 ± 5 0.008
Other coronary risk factors 2(7) 16(53) < 0.001
Baseline aPL frequencies(%):    
Blood samples n(%) 30(100) 29(97)* N/S
Anticardiolipin (IgG) 14(47) 3(10) 0.003
Anticardiolipin (IgM) 3(10) 1(3) N/S
Anticardiolipin (IgA) 0(0) 3(10) N/S
Beta-2 Glycoprotein (IgG) 11(37) 6(21) N/S
Beta-2 Glycoprotein (IgM) 3(10) 0(0) N/S
Beta-2 Glycoprotein (IgA) 7(23) 12(41) N/S
Anti-Prothrombin (IgG) 26(87) 6(21) < 0.001
Anti-Prothrombin (IgM) 2(7) 0(0) N/S
Anti-Prothrombin (IgA) 2(7) 1(3) N/S
Antiphospholipid syndrome (%): 8/18(44) 6/25(24) N/S
  1. Legend: Data are presented as the mean ± standard deviation or proportions
  2. Key: BMI = body mass index
  3. aPL = antiphospholipid antibody
  4. * 1 patient not analysed due to an inadequate blood sample